Mumbai/Melbourne/London — Rare, life-threatening Covid-19 complications appear to be escalating in India, creating a new wave of critical medical challenges in a country that has already seen short supplies of oxygen and other basic needs.

Pharmacists are warning of a shortage of a crucial drug to treat an invasive fungal infection preying on patients with weakened immune systems and diabetes. An uptick in cases across India of a dangerous inflammatory syndrome in children — also seen in the US and Europe at the height of their outbreaks — is a harbinger of a potentially deadly spate of the pediatric illness in the coming weeks...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.